SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

West Reports Third-Quarter 2026 Results

WST
SquawkNews Desk 1 updates Updated Oct 29, 2026, 10:01 AM UTC

Story updates

10:01:36 AM UTC
SquawkNews
Raising Full-Year Net Sales and Adjusted-Diluted EPS guidanceEXTON, Pa., Oct. 29, 2026 // -- West Pharmaceutical Services, Inc. (NYSE:WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the third quarter of 2026…

Related stories

Enerflex Q3 2026 Net Earnings Rise on Lower Costs and Losses Enerflex management attributed higher Q3 2026 net earnings to lower finance costs, taxes and redemption-option losses. M impact | EQUITY | Oct 29, 2026, 05:21 PM UTC Trading Resumes in Postmedia Network Canada Corp. Trading resumes in Postmedia Network Canada Corp. on the TSX. L impact | EQUITY | Oct 29, 2026, 05:20 PM UTC DLSI Announces Availability of Third-Quarter 2026 Revenue Release DLSI announced that its third-quarter 2026 revenue release is available. M impact | EQUITY | Oct 29, 2026, 05:19 PM UTC Dream raises $17 million in seed funding Dream emerged from stealth on Oct. 29 alongside its seed funding announcement. M impact | EQUITY | Oct 29, 2026, 05:18 PM UTC Landis+Gyr Reports Q2 2026 Net Revenue of $269.2 Million M impact | EQUITY | Oct 29, 2026, 05:17 PM UTC Nasdaq halts trading due to volatility M impact | EQUITY | Oct 29, 2026, 05:17 PM UTC